Dr. Reddys Laboratories Ltd.
BSE: 500124 | NSE: DRREDDY
Mid Cap | Pharmaceuticals & Drugs
1245.50
-24.30
(-1.91%)
< Home
< Back
Dr. Reddys Laboratories Ltd. News
>>
Dr. Reddy’s Laboratories gains on launching Bupropion HCI Tablets in US market
>>
Dr. Reddy’s Laboratories launches Bupropion HCI Tablets in US market
>>
Dr. Reddy’s Lab gains on launching unique patient-centric platform 'Purple Health'
>>
Dr. Reddy’s Lab launches unique patient-centric platform 'Purple Health'
>>
Dr. Reddy’s Lab gains on launching Nitroglycerin sublingual tablets USP in the U.S. Market
>>
Dr Reddys Laboratories informs about press release
>>
Dr. Reddy’s Lab launches Nitroglycerin sublingual tablets USP in the U.S. Market
>>
Dr. Reddy’s gets CDSCO nod to export 15 drugs to European Union market: Report
>>
Dr Reddys Laboratories informs about press release
>>
Dr. Reddy’s gains on completing acquisition of product portfolio from TEVA
<<
<
94
95
96
...143
>
>>